EUVIMEDDescubrir EUVIMED
ÜbersichtsarbeitOpen access

Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation

B Trijzelaar

Biotherapy · 1993

DOI: 10.1007/bf01877422 ↗

At a glance

Übersichtsarbeit in Biotherapy, 1993. Written by B Trijzelaar. Institution: Strategic Biotech International, Zeist, The Netherlands. Cited 11 times so far (Crossref). The full text is freely available in PubMed Central.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

No hay resumen disponible.

Subjects

MeSH terms (MEDLINE)

AnimalsBiotechnologyEuropean UnionGuidelines as TopicHumansQuality ControlReproducibility of ResultsViruses

Authors and institutions

  • Strategic Biotech International, Zeist, The Netherlands.

Cite

APA

Trijzelaar, B. (1993). Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. https://doi.org/10.1007/bf01877422

Vancouver

Trijzelaar B. Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. 1993. doi:10.1007/bf01877422

BibTeX
@article{Trijzelaar1993,
  author = {Trijzelaar, B},
  title = {Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation},
  journal = {Biotherapy},
  year = {1993},
  doi = {10.1007/bf01877422}
}
Start for free →